Sign in

NCT03993665Active, not recruiting

Use of Multiparametric MRI in the Management of Head and Neck Cancer: a Prospective Analysis

Use of Multiparametric Magnetic Resonance Imaging in the Management of Head and Neck Cancer: a Prospective Analysis

Source: ClinicalTrials.gov · Last updated 24 Feb 2022

Brief summary (registry, in English)

The investigators aim to validate specific MRI parameters that could improve diagnostic accuracy of metastatic cervical lymph nodes in patients with a squamous cell carcinoma in the head and neck region. Moreover, we aim to explore specific MRI parameters that could improve diagnostic accuracy of bone invasion and tumour relapse, as well as predict treatment response and survival in this target population.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
70 (actual)
First submitted
13 Feb 2019
Start date
20 Nov 2018
Primary completion date
31 Dec 2023
Lead sponsor
AZ Sint-Jan AV
NCT number
NCT03993665

What you commit to

  • Study type: Observational
  • Participants enrolled: 70
  • From 20 Nov 2018 to the primary completion date, 31 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • previously surgery, irradiation or chemotherapy in the HN region

Other illness

  • thyroid or skin cancer

Other

  • not fulfilling abovementioned criteria
  • considerable artefact on MRI

Who the study is looking for

  • Patients who received a pretreatment multiparametric MRI according to a standardized protocol
  • Histopathologically proven SCC in the HN region (affected group)
  • Histopathologically proven Whartin tumour or pleomorphic adenoma in the HN region without malignant transformation (control group)
  • Patients in whom a or multiple clearly distinguishable cervical lymph node(s) can be observed radiologically, and which can be correlated unambiguously with the pathology report

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Division of Maxillofacial Surgery, Department of Surgery, AZ Sint-Jan Brugge-Oostende AV
Coordinator of this site? Confirm its status
BrugesBelgiumUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.